Researchers urge greater awareness of delayed skin reactions to Moderna COVID-19 vaccine

(Massachusetts General Hospital) Researchers note that Phase 3 clinical data from the Moderna vaccine trial did show delayed skin hypersensitivity in a small number of the more than 30,000 trial participants. However, the authors say the large, red, sometimes raised, itchy or painful skin reactions were never fully characterized or explained, and they warn clinicians may not be prepared to recognize them and guide patients on treatment options and completion of the second dose of the vaccine.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news